Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 29229

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2021 | Month : August | Volume : 15 | Issue : 8 | Page : WC04 - WC07 Full Version

A Prospective Interventional Study of Xanthelasma Palpebrarum Treated with Ultrapulse Carbon Dioxide Laser


Published: August 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/49100.15283
Manjeet Naresh Ramteke, Usha Naraindas Khemani

1. Assistant Professor, Department of Dermatology, Venereology and Leprosy, Grant Government Medical College, Mumbai, Maharashtra, India. 2. Associate Professor, Department of Dermatology, Venereology and Leprosy, Grant Government Medical College, Mumbai, Maharashtra, India.

Correspondence Address :
Manjeet Naresh Ramteke,
Skin OPD, 1st Floor, Main OPD Building, G.T. Hospital Campus, Dhobi Talao, Mumbai-400001, Maharashtra, India.
E-mail: manjeetramteke@gmail.com

Abstract

Introduction: Xanthelasma palpebrarum (XP) is the most common of all the xanthomas which presents as asymptomatic, often bilateral, soft, yellow, papules and plaques around the eyelids. Although, the lesions are benign, it is aesthetically upsetting. The surgical laser is the most effective treatment modality to this problem.

Aim: To evaluate the efficacy and safety of ultrapulse Carbon dioxide (CO2) laser in XP in Indian patients.

Materials and Methods: It is a prospective, interventional study carried out for two years in which 29 patients with 61 XP lesions were part of the study. Ultrapulse CO2 (Fraxis Duo laser; 10,600 nm) laser treatment was done in every patient for a single sitting. Statistical significance was calculated using Chi-square test using Statistical Packages for Social Sciences (SPSS) version 19.0. The p-value of 0.001 was considered statistically significant.

Results: A total number of 29 patients with 61 xanthelasma lesions were included in the study, of which 11 were males and 18 were females with an age range of 27-54 years. In the present study XP lesions were completely resolved in majority (54 lesions in 25 patients) of treated patients. No intraoperative complications were observed. Two patients showed hypopigmentation. There was neither scarring nor recurrence seen after six months follow-up.

Conclusion: Ultrapulse CO2 laser is a safe and effective option of treatment for xanthelasma. It is considered as less painful procedure with fewer side effects and recurrences in the present study.

Keywords

Efficacy, Hypopigmentation, Xanthomas

The XP is a disorder which presents with symmetrical soft, yellowish papules and plaques on the inner canthi of upper and lower lids (1). It is one of the commonest xanthomas seen in dermatology practice that create aesthetic problem for patients. The exact cause of XP is not known, but factors such as hormonal, local and macrophage factors have been implicated in its pathogenesis. However, acetylated low density lipoproteins and macrophages with their scavenger receptor were newly described to be involved in the pathogenesis of XP (2). Xanthelasma usually occurs in persons above fifty years. About 50% have dyslipidaemia (high low density lipoproteins cholesterol and triglyceride, low high density lipoproteins cholesterol and apolipoprotein A-1) (3).

There are various treatment modalities for XP that include surgical removal, electrocauterisation, chemical cauterisation with Trichloroacetic Acid (TCA), cryotherapy, blepharoplasty and laser ablation (4). Various types of Light Amplification by Stimulated Emission of Radiation (laser) like CO2 laser in different modes (continuous, ultrapulse (5), and superpulse (6), potassium titanyl phosphate (KTP) laser (7), Erbium-Doped: Yttrium Aluminium Garnet (Er:YAG) laser (4), 1450 nm diode laser (8), 1064 nm Q switched Neodymium-Doped:Yttrium Aluminum Garnet (Nd:YAG) (9) and fractional CO2 laser (6),(10) have been used. CO2 laser is regarded as the gold-standard of all the ablative laser. The chromophore for CO2 laser is water whose vaporisation within the cells results in nonselective thermal damage and ablation of skin layer by layer. The ultrapulsed CO2 laser emit very short light pulses (600-900 μsec) with maximum peak energies (up to 500 mJ). It results in deepest penetration and narrow controlled thermal zone as the pulse duration which is short lies well beyond the thermal relaxation time of skin (5). Its concept lies in giving a uniform treatment zone by the laser causing skin surface vaporisation but accelerated re-epithelialisation from undamaged hair follicles and other adnexal structures (11).

All laser treatment offers moderate to excellent clearance rates with less side effects. Very few studies have been done in XP treated with Ultrapulse laser with fewer number of subjects. Most of the studies in which XP was treated with ultrapulse CO2 laser showed good efficacy and less side effects (5),(12),(13). Thus the present study was aimed to evaluate the efficacy and safety of ultrapulse CO2 laser in xanthelasma in Indian patients.

Material and Methods

A single centre, open label, non-randomised prospective interventional study was carried out in the Department of Dermatology, Venereology and Leprosy, Outpatient Department (OPD), Grant Government Medical College, Mumbai, Maharashtra, India, from January 2018 to January 2020 after obtaining the approval from Institutional Ethics Committee. Total sample size considered was 29 and subjects were selected using non probability convenience sampling technique.

Inclusion criteria: Patients diagnosed as XP and aged 25-60 years of either gender and those willing to participate in the study and giving valid consent for the same were included in the study.

Exclusion criteria: Active infection at the treatment site, history of keloids/hypertrophic scars, treatment taken for last six months, pregnant and lactating females and patients with unrealistic expectations were excluded in this study.

Baseline Evaluation

After obtaining informed consent baseline evaluation was done. This comprised a detailed history regarding the duration, any systemic co-morbidities, such as diabetes mellitus, or hypertension, any concomitant drug use by the patient, and a history suggestive of keloid or hypertrophic scar. Female patient’s status on pregnancy or lactation was also noted. A detailed clinical history, examination, and pretreatment clinical photographs were taken. The lesions of XP were examined for number, size, depth, and if it is unilateral or bilateral. The size of lesions was calculated using a measuring tape. Biochemical investigation that is lipid profile was carried out for all patients.

Treatment Protocol

Treatment of all the lesions of XP was done with ultrapulse CO2 laser (Fraxis duo CO2 laser; 10,600 nm wavelength; pulse energy 500 mJ/impulse; pulse duration 600-900 μsec, spot size of 1.1-1.5 mm). The patients were asked to close their eyes and an assistant holds the eye shield for protection. With all aseptic precautions, the lesions were infiltrated with 2% xylocaine before the procedure. While the laser procedure is being done, the skin layers were curated and the evaporated skin is wiped off with moist gauze. Layer by layer, the lesion was subjected to laser light till bleeding points appeared. Topical antibiotic was applied immediately after the procedure and for next seven days. Patients were advised not to touch or remove the crust over the operated area. The patients were asked to follow-up for six months. Pre and post laser photographic documentation was done. Every patient was looked for complications like secondary infection, post inflammatory hypo or hyperpigmentation, scar and ectropion.

Evaluation: Flattening and complete disappearance of the lesion of XP was considered as efficacy. The efficacy was done by clinical evaluation by a dermatologist by looking at the pre-treatment and post-treatment photographs and evaluated by considering a complete response (cleared completely), a partial response (50-70% reduction in original diameter), and no response (<50% reduction in size).

Statistical Analysis

The collected data were entered and analysed using SPSS version 19.0. Frequencies and percentages were computed for qualitative variables like gender and efficacy. Mean±SD for continuous variables like age was calculated. Chi-square test was used to compare efficacy of treatment in both eyes. The p-value of 0.001 was considered statistically significant.

Results

A total number of 29 patients with 61 xanthelasma lesions were treated with ultrapulse CO2 laser. Of these, 11 were males and 18 were females and age range from 27-54 years. Of all the lesions, seven lesions were >1 cm2 and 54 lesions were <1 cm2. Six patients had multiple xanthelasma (more than two). None of the patient had diabetes mellitus, or hypertension, any concomitant drug use. None of the patients had keloids/ hypertrophic scars. None of the female patients were pregnant or lactating. Five patients (17.2%) had deranged lipid profile (cholesterol and triglycerides). Of these, 54 lesions of xanthelasma were cleared completely with single sessions of ultrapulse CO2 laser (Table/Fig 1), (Table/Fig 2), (Table/Fig 3) (Table/Fig 4), while seven lesions required multiple sittings. Downtime was one week with crusted lesion. One patient had oedema over the operated lesions for three days which resolved with anti-inflammatory agents. There was no erythema or post inflammatory hyperpigmentation. There was hypopigmentation in two patients. All the patients were satisfied with the treatment. There were no complications (like haematoma, infection, bleeding, ectropion) encountered in any patient. There was no recurrence of lesion in any patient after six months.

Discussion

The XP is an asymptomatic benign disorder, without any functional disturbances; in spite of that patient seek treatment for aesthetic reasons. The classical treatment for XP is surgical excision but it has its limitation. It may lead to scarring, ectropion and is not feasible for very extensive lesion and may not be repeatable for relapses (14).

Ultrapulse CO2 laser is a mode with great outcome, fewer side effects and less downtime. In a study it has been shown have shown that by a single ultrapulsed CO2 laser treatment of 250 mJ impulses results in the ablation of skin upto 60 μm depth. A second laser application will further ablate to a depth of ~130 μm; a further abalation will lead to thermal destruction of skin structures to the extent of 316 μm, so that the ultrapulsed CO2 laser does an accurate and proper ablation of skin layers. Because of this accurate and superficial effect, there is less damage to delicate deeper structures, thereby limiting the occurrence of scarring and pigmentary changes. This property helps in controlled ablation of xanthelasma lesion with minimal adverse effects (5). In this study, most of the lesions of XP were cleared completely in one sitting except in few patients which may be because of the larger size and depth of the lesions. There were no side effect in any patients except hypopigmentation in two patients.

In a large case series of 23 patients with 52 xanthelasma by Raulin C et al., in 1999, concluded that ultrapulse CO2 laser is an effective and safe therapeutic option with no scarring, minimal side effects and a recurrence rate of 13% at 10 months (5). In another case series of 10 patients with 20 lesions by Pathania V and Chatterjee M showed complete removal in single session with less side effects and 20% recurrence rate (12). A study by Goel K et al., comparing the efficacy of 30% TCA and ultrapulse CO2 laser in XP concluded that both are good options for mild lesions, but laser is a better modality for severe lesions while there is recurrence with both (13). Similar results were found in present study, however there was no recurrence of lesions in any patient which may be because of short follow-up period. Hence, long term follow-up is required to get an accurate result. Also, most of the patients from the present study were below 50 years of age and there was dyslipidaemia in only 17% of patients in contrast to the literature where XP is common after the age of 50 years with dyslipidaemia in 50% patients. This may be because of younger population affected where exact cause is not clear.

Other treatment options for XP are topical TCA, cryotherapy, Er:YAG laser, Q-switched Nd:YAG laser, argon laser, KTP laser, pulsed dye laser, Diode laser and fractional CO2 laser. Topical TCA for XP is considered to be more effective for smaller lesions, but requires multiple sittings leading to post inflammatory pigmentation and scarring and recurrences ranging between 25% and 39% (15). A gentle liquid nitrogen cryotherapy can be used for xanthelasma owing to the ease of application and less side effects (16). Mannino G et al., stated that Er:YAG laser is an ablative laser that has a smaller thermal coagulation zone as compared to CO2 laser which has been used effectively in XP with no scarring or pigmentation, (17). Karsai S et al., suggested that Q-switched Nd:YAG (532 nm and 1064 nm) laser cannot be approved for the treatment of XP as most of patients showed poor or no clearance (18). Argon laser is a simple, effective, and safe method of treatment for small lesions of XP as it has short penetration depths but major disadvantage being significant recurrence rate (19). KTP laser is safe and highly effective for XP, but frequent treatments are required to maintain the desired results and avoid recurrence (20). While pulsed dye lasers are effective in early vascular lesions, they fare poorly in xanthelasmas. Diode lasers causes photothermal destruction of sebaceous glands in the mid-dermis and thus have been tried and showed efficacy in XP (15). The comparably high recurrence rate seems to be a classical characteristic of XP regardless of the mode of treatment which depends on factors such as depth, size, and extent of the lesion. Thus, it is necessary to have a standardised scoring system to compare various studies. In a nutshell, almost all the lasers require multiple sessions with varying rates of clearance and recurrence of lesions. Thus, with the advantages of a single treatment session, fewer side effects and low rates of recurrence by ultrapulse CO2 laser as compared to contemporary conventional treatments, ultrapulse CO2 laser can be the best therapeutic option in treatment of XP.

Limitation(s)

The exact recurrence rate in the present study could not be calculated because of short follow-up period. So, long term follow-up is required to assess it. Also, the modality of ultrapulse laser was not compared with any other modality to know the exact efficacy was another limitation of this study.

Conclusion

Ultrapulse CO2 laser is a safe and effective treatment of XP in the delicate periorbital area, advantages being no side effects and fewer recurrences. CO2 laser being outpatient procedure will reduce patient’s anxiety that is related to surgical intervention.

References

1.
Jain A, Goyal P, Nigam PK, Gurbaksh H, Sharma RC. Xanthelasma palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian Journal of Clinical Biochemistry. 2007;22(2):151-53. [crossref] [PubMed]
2.
Kavoussi H, Rezaei M, Najafi B, Ebrahimi A, Ramezani M, Kavoussi R. Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum. An Bras Dermatol. 2016;91(4):468-71. [crossref] [PubMed]
3.
Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: Clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181-88. [crossref] [PubMed]
4.
Güngör S, Canat D, Gökdemir G. Erbium: YAG laser ablation versus 70% Trichloroacetic acid in the treatment of Xanthelasma Palpebrarum. J Dermatology Treat. 2014;25(4):290-93. [crossref] [PubMed]
5.
Raulin C, Schoenermark MP, Werner S, Greve B. Xanthelasma palpebrarum: Treatment with the ultrapulsed CO2 laser. Lasers Surg Med. 1999;24(2):122-27. 3.0.CO;2-6>[crossref]
6.
Esmat SM, Elramly AZ, Abdel Halim DM, Gawdat HI, Taha HI. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: A randomized clinical trial. Dermatol Surg. 2014;40(12):1349-55. [crossref] [PubMed]
7.
Berger C, Kopera D. KTP laser coagulation for xanthelasma palpebrarum. J Dtsch Dermatol Ges. 2005;3(10):775-79. [crossref] [PubMed]
8.
Park EJ, Youn SH, Cho EB, Lee GS, Hann SK, Kim KH, et al. Xanthelasma palpebrarum treatment with a 1450-nm-diode laser. Dermatol surg. 2011;37(6):791-96. [crossref] [PubMed]
9.
Zhao Y, Wen CM, Zhou NN, Feng Q, Tu P. 1064-nm Q- switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian popolation. J Eur Acad Dermatol Venereol. 2015;29(11):2263-65. [crossref] [PubMed]
10.
Burns T, Breathnach S, Cox N, Griffiths C, ed. (2010) Rook’s Textbook of Dermatology. eighth edition. United Kingdom: Wiley- Blackwell. [crossref]
11.
Roh HJ, Ryu DJ, Jung JY, Lee SH, Lee JH. Treatment of xanthelasma by Fractional CO2 laser. J Am Acad Dermatol. 2010.
12.
Pathania V, Chatterjee M. Ultrapulse carbon dioxide laser ablation of xanthelasmapalpebrarum: A case series. J Cutan Aesthet Surg. 2015;8(1):46-49. [crossref] [PubMed]
13.
Goel K, Sardana K, Garg VK. A prospective study comparing ultrapulse CO2 laser and trichloroacetic acid in treatment of xanthelasma palpebrarum. Journal of cosmetic dermatology. 2015;14(2):130-39. [crossref] [PubMed]
14.
Nguyen AH, Vaudreuil AM, Hueter CJ. Systemic review of laser therapy in xanthelasma palpebrarum. International J Dermatol. 2017;56(3):47-55. [crossref] [PubMed]
15.
Laftah Z, Al-Niaimi F. Xanthelasma: An update on treatment modalities. J Cutan Aesthet Surg. 2018;11(1):01-06. [crossref] [PubMed]
16.
Labandeira J, Vázquez-Osorio I, Figueroa-Silva O, Pereiro M Jr, Toribio J. Tolerability and effectiveness of liquid nitrogen spray cryotherapy with very short freeze times in the treatment of xanthelasmapalpebrarum. Dermatol Ther. 2015;28(6):346-50. [crossref] [PubMed]
17.
Mannino G, Papale A, De Bella F, Mollo R, Morgia P, Gabrieli CB. Use of Erbium: YAG laser in the treatment of palpebral xanthelasmas. Ophthalmic Surg Lasers. 2001;32(2):129-33. [crossref] [PubMed]
18.
Karsai S, Schmitt L, Raulin C. Is Q-switched neodymium-dopedyttrium aluminum garnet laser an effective approach to treat xanthelasma palpebrarum. Results from a clinical study of 76 cases. Dermatol Surg. 2009;35(12):1962-69. [crossref] [PubMed]
19.
Abdelkader M, Alashry SE. Argon laser versus erbium: YAG laser in the treatment of xanthelasma palpebrarum. Saudi J Ophthalmol. 2015;29(2):116-20. [crossref] [PubMed]
20.
Greijmans E, Luiting-Welkenhuyzen H, Luijks H, Bovenschen HJ. Continuous wave potassium titanyl phosphate laser treatment is safe and effective for xanthelasma palpebrarum. Dermatol Surg. 2016;42(7):860-66. [crossref] [PubMed]

DOI and Others

10.7860/JCDR/2021/49100.15283

Date of Submission: Feb 20, 2021
Date of Peer Review: Apr 24, 2021
Date of Acceptance: May 21, 2021
Date of Publishing: Aug 01, 2021

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Feb 22, 2021
• Manual Googling: Apr 24, 2021
• iThenticate Software: Jun 03, 2021 (9%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com